BTK inhibitors (MannKind)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameBTK inhibitors (MannKind)

Drug Alias NameBTK modulators (MannKind)BTK modulators (Tolero)bruton tyrosine kinase modulators (Tolero)bruton tyrosine kinase modulators (MannKind)MKC-4659

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTyrosine-protein kinase BTK inhibitors

TargetsTyrosine-protein kinase BTK

Therapy Area/IndicationsInflammationHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMannKind Corp Tolero Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsInflammationHematologic Neoplasms

Other Information

ATC CodeN/A